+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Bronchitol - Product Thumbnail Image

Bronchitol

  • Report
  • September 2018
  • 17 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis Forecast and Market Analysis for 2035 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis Forecast and Market Analysis for 2035

  • Drug Pipelines
  • August 2018
  • 171 Pages
  • Global
From
Spiriva - Product Thumbnail Image

Spiriva

  • Report
  • July 2018
  • 33 Pages
  • Global
From
Symbicort - Product Thumbnail Image

Symbicort

  • Report
  • July 2018
  • 30 Pages
  • Global
From
Nucala - Product Thumbnail Image

Nucala

  • Report
  • July 2018
  • 27 Pages
  • Global
From
Breo Ellipta - Product Thumbnail Image

Breo Ellipta

  • Report
  • July 2018
  • 41 Pages
  • Global
From
Drug Overview: Cinqair - Product Thumbnail Image

Drug Overview: Cinqair

  • Report
  • February 2018
  • 16 Pages
  • Global
From
Drug Overview: Fasenra - Product Thumbnail Image

Drug Overview: Fasenra

  • Report
  • February 2018
  • 23 Pages
  • Global
From
Drug Analysis: Cinqair - Product Thumbnail Image

Drug Analysis: Cinqair

  • Drug Pipelines
  • February 2018
  • 16 Pages
  • Global
From
Drug Analysis: Trelegy Ellipta - Product Thumbnail Image

Drug Analysis: Trelegy Ellipta

  • Drug Pipelines
  • February 2018
  • 16 Pages
  • Global
From
Asthma Forecast and Market Analysis to 2024 - Product Thumbnail Image

Asthma Forecast and Market Analysis to 2024

  • Report
  • February 2018
  • 680 Pages
  • Global
From
From
From
Research Report on China's Ceftriaxone Export 2023-2032 - Product Thumbnail Image

Research Report on China's Ceftriaxone Export 2023-2032

  • Report
  • January 2023
  • 50 Pages
  • China
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more